serine has been researched along with 2019 Novel Coronavirus Disease in 19 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "D-cycloserine (D-CS) is a second-line antibiotic for TB that inhibits bacterial cell wall synthesis." | 1.91 | Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model. ( Balaram, A; Conrad, WH; Dejneka, S; McMahon, M; Najibi, Z; Pawlowicz, P; Robbins, L, 2023) |
| "By the end of December 2021, coronavirus disease 2019 (COVID-19) produced more than 271 million cases and 5." | 1.72 | Transmembrane protease serine 2 ( ( Abad-Santos, F; Arévalo-Román, C; Campos-Norte, P; de Los Santos, I; Delgado-Wicke, P; Fernández de Córdoba-Oñate, S; Fernández-Campos, P; Fernández-Rico, M; Fernández-Ruiz, E; García-Fraile Fraile, L; González-Álvaro, I; Rivas-Durán, R; Sanz, J; Soria-Chacartegui, P; Villapalos-García, G; Zubiaur, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 19 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, JW | 1 |
| Chong, ETJ | 1 |
| Lee, PC | 1 |
| Arefin, S | 1 |
| Hernandez, L | 1 |
| Ward, LJ | 1 |
| Schwarz, A | 1 |
| Barany, P | 1 |
| Stenvinkel, P | 1 |
| Kublickiene, K | 1 |
| Villapalos-García, G | 1 |
| Zubiaur, P | 1 |
| Rivas-Durán, R | 1 |
| Campos-Norte, P | 1 |
| Arévalo-Román, C | 1 |
| Fernández-Rico, M | 1 |
| García-Fraile Fraile, L | 1 |
| Fernández-Campos, P | 1 |
| Soria-Chacartegui, P | 1 |
| Fernández de Córdoba-Oñate, S | 1 |
| Delgado-Wicke, P | 1 |
| Fernández-Ruiz, E | 1 |
| González-Álvaro, I | 1 |
| Sanz, J | 1 |
| Abad-Santos, F | 1 |
| de Los Santos, I | 1 |
| Chan, JF | 1 |
| Hu, B | 1 |
| Chai, Y | 1 |
| Shuai, H | 1 |
| Liu, H | 1 |
| Shi, J | 1 |
| Liu, Y | 1 |
| Yoon, C | 1 |
| Zhang, J | 1 |
| Hu, JC | 1 |
| Hou, Y | 1 |
| Huang, X | 1 |
| Yuen, TT | 1 |
| Zhu, T | 1 |
| Li, W | 1 |
| Cai, JP | 1 |
| Luo, C | 1 |
| Yip, CC | 1 |
| Zhang, AJ | 1 |
| Zhou, J | 1 |
| Yuan, S | 1 |
| Zhang, BZ | 1 |
| Huang, JD | 1 |
| To, KK | 1 |
| Yuen, KY | 1 |
| Chu, H | 1 |
| Yaron, TM | 1 |
| Heaton, BE | 1 |
| Levy, TM | 1 |
| Johnson, JL | 1 |
| Jordan, TX | 1 |
| Cohen, BM | 1 |
| Kerelsky, A | 1 |
| Lin, TY | 1 |
| Liberatore, KM | 1 |
| Bulaon, DK | 1 |
| Van Nest, SJ | 1 |
| Koundouros, N | 1 |
| Kastenhuber, ER | 1 |
| Mercadante, MN | 1 |
| Shobana-Ganesh, K | 1 |
| He, L | 1 |
| Schwartz, RE | 1 |
| Chen, S | 1 |
| Weinstein, H | 1 |
| Elemento, O | 1 |
| Piskounova, E | 1 |
| Nilsson-Payant, BE | 1 |
| Lee, G | 1 |
| Trimarco, JD | 1 |
| Burke, KN | 1 |
| Hamele, CE | 1 |
| Chaparian, RR | 1 |
| Harding, AT | 1 |
| Tata, A | 1 |
| Zhu, X | 1 |
| Tata, PR | 1 |
| Smith, CM | 1 |
| Possemato, AP | 1 |
| Tkachev, SL | 1 |
| Hornbeck, PV | 1 |
| Beausoleil, SA | 1 |
| Anand, SK | 1 |
| Aguet, F | 1 |
| Getz, G | 1 |
| Davidson, AD | 1 |
| Heesom, K | 1 |
| Kavanagh-Williamson, M | 1 |
| Matthews, DA | 1 |
| tenOever, BR | 1 |
| Cantley, LC | 1 |
| Blenis, J | 1 |
| Heaton, NS | 1 |
| Higashi-Kuwata, N | 1 |
| Yabe, SG | 1 |
| Fukuda, S | 1 |
| Nishida, J | 1 |
| Tamura-Nakano, M | 1 |
| Hattori, SI | 1 |
| Okochi, H | 1 |
| Mitsuya, H | 1 |
| Kaidashev, I | 1 |
| Izmailova, O | 1 |
| Shlykova, O | 1 |
| Kabaliei, A | 1 |
| Vatsenko, A | 1 |
| Ivashchenko, D | 1 |
| Dudchenko, M | 1 |
| Volianskyi, A | 1 |
| Zelinskyy, G | 1 |
| Koval, T | 1 |
| Dittmer, U | 1 |
| Lee, E | 1 |
| Redzic, JS | 1 |
| Saviola, AJ | 1 |
| Li, X | 1 |
| Ebmeier, CC | 1 |
| Kutateladze, T | 1 |
| Hansen, KC | 1 |
| Zhao, R | 1 |
| Ahn, N | 1 |
| Sluchanko, NN | 1 |
| Eisenmesser, E | 1 |
| Miyoshi, H | 1 |
| Otomo, M | 1 |
| Takahashi, K | 1 |
| Robbins, L | 1 |
| Balaram, A | 1 |
| Dejneka, S | 1 |
| McMahon, M | 1 |
| Najibi, Z | 1 |
| Pawlowicz, P | 1 |
| Conrad, WH | 1 |
| Spinello, A | 1 |
| D'Anna, L | 1 |
| Bignon, E | 1 |
| Miclot, T | 1 |
| Grandemange, S | 1 |
| Terenzi, A | 1 |
| Barone, G | 1 |
| Barbault, F | 1 |
| Monari, A | 1 |
| De Angelis, M | 1 |
| Anichini, G | 1 |
| Palamara, AT | 1 |
| Nencioni, L | 1 |
| Gori Savellini, G | 1 |
| Strobelt, R | 1 |
| Adler, J | 1 |
| Shaul, Y | 1 |
| Hora, S | 1 |
| Pahwa, P | 1 |
| Siddiqui, H | 1 |
| Saxena, A | 1 |
| Kashyap, M | 1 |
| Sevak, JK | 1 |
| Singh, R | 1 |
| Javed, M | 1 |
| Yadav, P | 1 |
| Kale, P | 1 |
| Ramakrishna, G | 1 |
| Bajpai, M | 1 |
| Rathore, A | 1 |
| Maras, JS | 1 |
| Tyagi, S | 1 |
| Sarin, SK | 1 |
| Trehanpati, N | 1 |
| Pham, NT | 1 |
| Phan, LT | 1 |
| Seo, J | 1 |
| Kim, Y | 1 |
| Song, M | 1 |
| Lee, S | 1 |
| Jeon, YJ | 1 |
| Manavalan, B | 1 |
| Kumar, V | 1 |
| Dhanjal, JK | 1 |
| Bhargava, P | 1 |
| Kaul, A | 1 |
| Wang, J | 1 |
| Zhang, H | 1 |
| Kaul, SC | 1 |
| Wadhwa, R | 1 |
| Sundar, D | 1 |
| Benedetti, F | 1 |
| Snyder, GA | 1 |
| Giovanetti, M | 1 |
| Angeletti, S | 1 |
| Gallo, RC | 1 |
| Ciccozzi, M | 1 |
| Zella, D | 1 |
| Wambier, CG | 1 |
| McCoy, J | 1 |
| Goren, A | 1 |
| Zhang, Y | 1 |
| Guo, R | 1 |
| Kim, SH | 1 |
| Shah, H | 1 |
| Zhang, S | 1 |
| Liang, JH | 1 |
| Fang, Y | 1 |
| Gentili, M | 1 |
| Leary, CNO | 1 |
| Elledge, SJ | 1 |
| Hung, DT | 1 |
| Mootha, VK | 1 |
| Gewurz, BE | 1 |
2 reviews available for serine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Humans; Peptidyl-Dipeptidase A; Pharmaceutical Preparatio | 2022 |
Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Humans; Membrane Proteins; Oxygen; Peptidyl-Dipeptidase A | 2023 |
17 other studies available for serine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Female; Humans; Kidney Failure, Chronic; Male; Peptidyl-D | 2022 |
Transmembrane protease serine 2 (
Topics: Comorbidity; COVID-19; Female; Humans; Male; Serine; Serine Endopeptidases; Severity of Illness Inde | 2022 |
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2.
Topics: Animals; COVID-19; Humans; Mice; SARS-CoV-2; Serine; Virulence | 2022 |
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.
Topics: Animals; COVID-19; Glycogen Synthase Kinase 3; Humans; Mammals; Nucleocapsid; Nucleocapsid Proteins; | 2022 |
Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Drug Evaluation; Humans; Induced Pluripotent Stem Cells; | 2022 |
Molecular insight into the specific interactions of the SARS-Coronavirus-2 nucleocapsid with RNA and host protein.
Topics: Arginine; COVID-19; Cyclophilins; Humans; NIMA-Interacting Peptidylprolyl Isomerase; Nucleocapsid; N | 2023 |
Clomipramine inhibits dynamin GTPase activity by L-α-phosphatidyl-L-serine stimulation.
Topics: Clathrin; Clomipramine; COVID-19; Dynamin I; Dynamins; Endocytosis; Humans; Protein Isoforms; SARS-C | 2023 |
Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model.
Topics: Acetyl Coenzyme A; Anti-Bacterial Agents; COVID-19; Cycloserine; Humans; Serine; Tuberculosis | 2023 |
Mechanism of the Covalent Inhibition of Human Transmembrane Protease Serine 2 as an Original Antiviral Strategy.
Topics: Antiviral Agents; Cell Membrane; COVID-19; Humans; SARS-CoV-2; Serine | 2023 |
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.
Topics: Antioxidants; COVID-19; Homeostasis; Humans; NF-E2-Related Factor 2; Oxidation-Reduction; SARS-CoV-2 | 2023 |
The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.
Topics: COVID-19; Humans; Peptide Hydrolases; SARS-CoV-2; Serine; Serine Endopeptidases; Spike Glycoprotein, | 2023 |
Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
Topics: COVID-19; Cytokines; Female; Glycine; Humans; Immunity; Infant, Newborn; Interferon-alpha; Interleuk | 2023 |
Advancing the accuracy of SARS-CoV-2 phosphorylation site detection via meta-learning approach.
Topics: COVID-19; Humans; Phosphorylation; SARS-CoV-2; Serine; Threonine | 2023 |
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells.
Topics: Binding Sites; COVID-19; Humans; MCF-7 Cells; Molecular Docking Simulation; Plant Extracts; SARS-CoV | 2022 |
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Topics: Amino Acid Sequence; Base Sequence; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus In | 2020 |
Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals.
Topics: Androgens; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Male; Pandemics; Pneumonia, Vi | 2020 |
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
Topics: A549 Cells; Animals; Carbon; Chlorocebus aethiops; COVID-19; Cytopathogenic Effect, Viral; Folic Aci | 2021 |